BRIGHT MINDS BIOSCIENCES INC. Adjustments For Depreciation And Amortisation Expense
BRIGHT MINDS BIOSCIENCES INC. (DRUG) reported Adjustments For Depreciation And Amortisation Expense of CAD 73.36 thousand for the 12-month period ending 2024-09-30, per its 20-F filed 2024-12-31.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense · last filed 2024-12-31
| Period end | Adjustments For Depreciation And Amortisation Expense 12 month |
|---|---|
| 2024-09-30 | 73.36K CAD 20-F · filed 2024-12-31 |
| 2023-09-30 | 72.45K CAD 20-F · filed 2024-12-31 |
| 2022-09-30 | 6.04K CAD 20-F · filed 2024-12-31 |
| 2021-09-30 | 0.00 CAD 20-F · filed 2023-12-29 |
| 2020-09-30 | 0.00 CAD 20-F · filed 2022-12-29 |